See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636282_2019_Aeglea_BioTherapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001636282, Aeglea BioTherapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 76,671,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,018,000 |
| 3 | remainder_Assets | 50,000 |
| 4 | LiabilitiesCurrent | 10,239,000 |
| 5 | LiabilitiesNoncurrent | 72,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,632,000 |
| 9 | ResearchAndDevelopmentExpense | 36,719,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,888,000 |
| 12 | remainder_NetIncome | 1,115,000 |
| 13 | remainder_ComprehensiveNetIncome | 75,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 77,739,000 |
| 1 | Liabilities | 10,311,000 |
| 2 | Expenses | 49,351,000 |
| 3 | Revenues | 3,888,000 |
| 4 | StockholdersEquity | 67,428,000 |
| 5 | NetIncome | -44,348,000 |
| 6 | ComprehensiveNetIncome | -44,310,500 |
| 7 | BaseVar | 71,239,500 |
| 8 | EconomicCapitalRatio | 1.63 |
Edgar->Model Mapping
Feature Distribution
Change over Time
